医学
重症监护医学
生物标志物
护理管理
患者评估
患者安全
梅德林
急诊医学
还原(数学)
疾病管理
医疗急救
案例管理
疾病
护理评估
风险评估
摘要
In older patients receiving mavacamten, a reduction in NT-proBNP levels may coexist with persistent severe LVOTO. Nurses should interpret this biomarker-echocardiography discordance as a safety signal and maintain structured cardiovascular surveillance rather than assuming treatment success based solely on biomarker improvement.
科研通智能强力驱动
Strongly Powered by AbleSci AI